General issues related to rare disease treatment development.
2026 · 1st Quarter (Jan 1 - Mar 31)
RARE DISEASE COMPANY COALITION
Filed by FEROX STRATEGIES.
Open official filingSource-reported fields
Filing overview
- Type
- 1st Quarter - Report
- Posted
- Apr 18, 2026
- Income
- $50,000.00
- Expenses
- Not reported
- Registrant
- FEROX STRATEGIES
- Filing UUID
- 7b5a3091-ddb9-4dd5-8573-3ffabbef7187
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
General issues related to rare disease treatment.
General issues related to tariffs.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.